These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 9366426)

  • 1. Natural killer cell cytokine production, not cytotoxicity, contributes to resistance against blood-stage Plasmodium chabaudi AS infection.
    Mohan K; Moulin P; Stevenson MM
    J Immunol; 1997 Nov; 159(10):4990-8. PubMed ID: 9366426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-gamma and TNF-alpha and occurs via a nitric oxide-dependent mechanism.
    Stevenson MM; Tam MF; Wolf SF; Sher A
    J Immunol; 1995 Sep; 155(5):2545-56. PubMed ID: 7650384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo IL-12 production and IL-12 receptors beta1 and beta2 mRNA expression in the spleen are differentially up-regulated in resistant B6 and susceptible A/J mice during early blood-stage Plasmodium chabaudi AS malaria.
    Sam H; Stevenson MM
    J Immunol; 1999 Feb; 162(3):1582-9. PubMed ID: 9973416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the spleen B-cell compartment at the early and late blood-stage Plasmodium chabaudi malaria.
    Castillo-Méndez SI; Zago CA; Sardinha LR; Freitas do Rosário AP; Alvarez JM; D'Império Lima MR
    Scand J Immunol; 2007; 66(2-3):309-19. PubMed ID: 17635808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural regulatory (CD4+CD25+FOXP+) T cells control the production of pro-inflammatory cytokines during Plasmodium chabaudi adami infection and do not contribute to immune evasion.
    Cambos M; Bélanger B; Jacques A; Roulet A; Scorza T
    Int J Parasitol; 2008 Feb; 38(2):229-38. PubMed ID: 17868677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection.
    Orange JS; Biron CA
    J Immunol; 1996 Jun; 156(12):4746-56. PubMed ID: 8648121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible modulation by male sex hormone of Th1/Th2 function in protection against Plasmodium chabaudi chabaudi AS infection in mice.
    Zhang Z; Chen L; Saito S; Kanagawa O; Sendo F
    Exp Parasitol; 2000 Nov; 96(3):121-9. PubMed ID: 11162362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium chabaudi chabaudi: differential susceptibility of gene-targeted mice deficient in IL-10 to an erythrocytic-stage infection.
    Linke A; Kühn R; Müller W; Honarvar N; Li C; Langhorne J
    Exp Parasitol; 1996 Nov; 84(2):253-63. PubMed ID: 8932775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
    Gill N; Rosenthal KL; Ashkar AA
    J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells.
    Byrne P; McGuirk P; Todryk S; Mills KH
    Eur J Immunol; 2004 Sep; 34(9):2579-88. PubMed ID: 15307190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-12 is required for antibody-mediated protective immunity against blood-stage Plasmodium chabaudi AS malaria infection in mice.
    Su Z; Stevenson MM
    J Immunol; 2002 Feb; 168(3):1348-55. PubMed ID: 11801675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pathogenic role of IL-12 in blood-stage murine malaria lethal strain Plasmodium berghei NK65 infection.
    Yoshimoto T; Takahama Y; Wang CR; Yoneto T; Waki S; Nariuchi H
    J Immunol; 1998 Jun; 160(11):5500-5. PubMed ID: 9605153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-12 corrects severe anemia during blood-stage Plasmodium chabaudi AS in susceptible A/J mice.
    Mohan K; Stevenson MM
    Exp Hematol; 1998 Jan; 26(1):45-52. PubMed ID: 9430513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo effects of mercuric chloride on thymic endocrine activity, NK and NKT cell cytotoxicity, cytokine profiles (IL-2, IFN-gamma, IL-6): role of the nitric oxide-L-arginine pathway.
    Santarelli L; Bracci M; Mocchegiani E
    Int Immunopharmacol; 2006 Mar; 6(3):376-89. PubMed ID: 16428073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18.
    Lauwerys BR; Renauld JC; Houssiau FA
    Cytokine; 1999 Nov; 11(11):822-30. PubMed ID: 10547269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early IL-12 p70, but not p40, production by splenic macrophages correlates with host resistance to blood-stage Plasmodium chabaudi AS malaria.
    Sam H; Stevenson MM
    Clin Exp Immunol; 1999 Aug; 117(2):343-9. PubMed ID: 10444268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmodium chabaudi adami: interferon-gamma but not IL-2 is essential for the expression of cell-mediated immunity against blood-stage parasites in mice.
    Batchelder JM; Burns JM; Cigel FK; Lieberg H; Manning DD; Pepper BJ; Yañez DM; van der Heyde H; Weidanz WP
    Exp Parasitol; 2003 Oct; 105(2):159-66. PubMed ID: 14969693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opsonin-independent phagocytosis: an effector mechanism against acute blood-stage Plasmodium chabaudi AS infection.
    Su Z; Fortin A; Gros P; Stevenson MM
    J Infect Dis; 2002 Nov; 186(9):1321-9. PubMed ID: 12402202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1.
    Bukowski JF; Welsh RM
    J Immunol; 1986 May; 136(9):3481-5. PubMed ID: 2420892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.